Towards Healthcare
Chronic Lower Back Pain Market Size and Companies Report by 2033

Chronic Lower Back Pain Market Size Envisioned at USD 6.12 Billion by 2033

The report covers Chronic Lower Back Pain Market Manufacturers and Segments Outlook starting with drug classes such as Non-steroidal Anti-inflammatory Drugs, Antidepressants, Analgesics, Opioids and others. It examines administration routes including oral, topical and others. The report assesses distribution channels, highlighting the roles of hospital pharmacies and retail & online pharmacies. Geographically, the analysis spans North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. The report offers the value (in USD Billion) for the above segments.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Chronic Lower Back Pain Market Assessment

  • Overview
  • Global Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Non-steroidal Anti-inflammatory Drugs
    • Antidepressants
    • Analgesic
    • Opioids
    • Others
  • Global Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • Global Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail & Online Pharmacies
  • Global Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Region (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

North America Chronic Lower Back Pain Market Assessment

  • Overview
  • North America Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Non-steroidal Anti-inflammatory Drugs
    • Antidepressants
    • Analgesic
    • Opioids
    • Others
  • North America Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • North America Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail & Online Pharmacies

Europe Chronic Lower Back Pain Market Assessment

  • Overview
  • Europe Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Non-steroidal Anti-inflammatory Drugs
    • Antidepressants
    • Analgesic
    • Opioids
    • Others
  • Europe Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • Europe Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail & Online Pharmacies

Asia Pacific Chronic Lower Back Pain Market Assessment

  • Overview
  • Asia Pacific Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Non-steroidal Anti-inflammatory Drugs
    • Antidepressants
    • Analgesic
    • Opioids
    • Others
  • Asia Pacific Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • Asia Pacific Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail & Online Pharmacies

Latin America Chronic Lower Back Pain Market Assessment

  • Overview
  • Latin America Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Non-steroidal Anti-inflammatory Drugs
    • Antidepressants
    • Analgesic
    • Opioids
    • Others
  • Latin America Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • Latin America Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail & Online Pharmacies

Middle East & Africa Chronic Lower Back Pain Market Assessment

  • Overview
  • Middle East & Africa Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Non-steroidal Anti-inflammatory Drugs
    • Antidepressants
    • Analgesic
    • Opioids
    • Others
  • Middle East & Africa Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • Middle East & Africa Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail & Online Pharmacies

Company Profiles

  • SpineThera Inc. (U.S.)
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Pfizer Inc (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Johnson & Johnson Private Limited (U.S.)
  • Medtronic (Ireland)
  • Endo Pharmaceuticals Inc. (Ireland)
  • Sanofi (France)
  • Merck & Co Inc. (U.S.)
  • Koninklijke Philips N.V. (Netherlands)
  • Vertebral Technologies, Inc. (U.S.)
  • Boston Scientific Corporation (U.S.)
  • Dr. Reddy’s Laboratories Ltd. (India)
  • Astellas Pharma Inc. (Japan)
  • CELGENE CORPORATION (U.S.)

Conclusion & Recommendations

  • Insight Code: 5156
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: June 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a dedicated market research professional with over 2 years of experience in the healthcare industry. Specializing in healthcare market research, she brings valuable expertise in analyzing market trends, evaluating industry dynamics, and providing actionable insights to help businesses stay ahead in a competitive market.

Throughout her career, Deepa has focused on delivering in-depth research on various healthcare segments, including pharmaceuticals, biotechnology, and healthcare services. She excels in identifying emerging opportunities, assessing market risks, and understanding regulatory changes that impact the healthcare sector.

Her ability to synthesize complex data and translate it into clear, concise recommendations makes her a key contributor to successful strategic decision-making. Her work helps organizations better understand consumer behavior, market demands, and the regulatory landscape, facilitating informed business strategies.

With a passion for healthcare research and a commitment to excellence, Deepa continues to provide businesses with the market intelligence they need to thrive in an increasingly complex healthcare environment. Her insights are critical for companies seeking to navigate the evolving healthcare landscape and optimize their market positioning.

FAQ's

Physical therapy, home exercise, meditation, proper diet, modification of lifestyle, use of injectables and pharmacologic treatments.

Spine X-ray, MRI, CT scan, electromyography and other tests depending on the cause of the pain.

FDA, World Health Organization, Centers for Disease Control and Prevention, American Association of Neurological Surgeons, National Institute of Health and Bone and Joint Canada.

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 515

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 515